1933 Industries Inc. (the “Company” or “1933 Industries”) (CSE: TGIF) (OTCQX: TGIFF), a vertically integrated cannabis consumer packaged goods company, is pleased to announce that it commenced the transfer of cannabis plants to its new cultivation facility in Las Vegas following an extensive period of systems-wide testing.
“This is a brand new facility and we worked around the clock to ensure that all systems were operational before transferring our plants”, commented Mr. Tim Spencer, Director of Cultivation. The new facility allows the Company to cultivate five times the amount of cannabis flower that was previously produced to meet the high demand for its branded flower and concentrate products under the Alternative Medicine Association (AMA) line, which are sold in licensed dispensaries in Nevada. AMA also produces well-known brands such as Gotti’s Gold, Kurupt’s Moonrocks, and Denver Dab Co. under licensing agreements. The increased flower production in the new facility will meet growing demand for premium cannabis products and will have a significant impact on the Company’s bottom line.
The Company will welcome OG DNA Genetics (DNA), a globally recognized leader in the research and development of cannabis genetics, to its new facility. DNA selected AMA as its partner in Nevada due to the Company’s advanced facility, extensive distribution channels and high-quality standards. DNA will provide specific expertise to AMA for the development of a consistent phenotype strain for a new line of co-branded flower and pre-rolls.
“We have constructed a one-of-a-kind, purpose-built facility, integrated with the latest technology to increase yields, bolster plant health and assure the consistency and quality of our products”, said Mr. Chris Rebentisch, CEO. “As experienced cultivators, we understand that controlling the growing environment is the most important part of cultivating high-quality craft cannabis at scale, which is why we spent significant time, capital and management’s time to build a state-of-the-art indoor facility. We are investing in assets that will provide a continuous supply of the raw materials necessary to produce our premium cannabis products and improve our margins”.
In order to verify that the plants are receiving exact amounts of nutrients and moisture content, the facility was outfitted with drip automation in order to standardize cultivation techniques and implement efficient watering and feeding systems with waste reduction in mind. “We can exactly measure the water and air content, meaning we are driving each plant’s growth with actual data instead of subjective opinion. This level of refinement is further testament to our commitment to consistent quality,” added Mr. Spencer.
Once the cannabis plants are situated in the new facility, they will vegetate for approximately four weeks before the flower cycle is begun for another eight weeks. The next steps include harvesting, drying, packaging and third-party testing. The entire cycle takes approximately 16 weeks.
About 1933 Industries Inc.
1933 Industries Inc. is a vertically integrated, brand-focused cannabis company with operations in the United States and Canada. Operating through two subsidiary companies, the Company owns leading cannabis brands as well as licensed cannabis cultivation, extraction, processing and manufacturing assets. With the goal of delivering natural wellness, our award-winning proprietary portfolio of brands include: AMA flower and AMA concentrates, CBD-infused Canna Hemp™, Canna Hemp X™, and Canna Fused™. Partners under licensing agreements include Denver Dab Co., Birdhouse Skateboards™, Gotti’s Gold and Kurupt Moonrocks. The Company owns 91% of Alternative Medicine Association, LC (AMA), and 100% of Infused MFG.
About Canna Hemp™
Canna Hemp™ CBD Relief Cream was named “Best Topical” by Leafy’s Best in State: The Top State Specific Products and Experiences of 2018.
About Canna HempX™
Canna Hemp X™ was named “Best Topicals for Pain” by Herb’s Guide to the Best Cannabis Products on the Planet. Canna Hemp X™ is a CBD sports recovery cream for athletes, bridging the gap between recovery and top performance.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. 1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.
SOURCE 1933 Industries Inc.
For further information: Alexia Helgason, Corporate Communications Director, 604-674-4756 (ext. 1), email@example.com; Chris Rebentisch, CEO & Director, 604-674-4756 (ext. 1)